OraSure Technologies, Inc.'s Intercept Oral Fluid Drug Test Results Comparable to Urine Drug Screening According to Landmark Five-Year Analysis

BETHLEHEM, Pa.--(BUSINESS WIRE)--OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that findings from a recent large-scale study of laboratory-based oral fluid drug testing results are comparable to urine drug testing positive rates for the same classes of drugs. The 650,000 oral fluid laboratory test results analyzed, of which 98% were conducted with the Intercept® oral fluid drug testing system, were collected over a five-year period of time in the non-federally regulated workplace market.